Welcome to our dedicated page for REGENCY CENTERS SEC filings (Ticker: REG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on REGENCY CENTERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into REGENCY CENTERS's regulatory disclosures and financial reporting.
C. Ronald Blankenship, a director of Regency Centers Corporation (REG), received 479 shares of common stock as payment of director fees under Regency's Omnibus Incentive Plan. The transaction is reported in Table I as a non-derivative acquisition (code A) and increases his direct beneficial ownership to 111,397 shares. The Form 4 indicates no derivative securities were acquired or disposed of and lists the reporting relationship as Director. The filing also shows the Form was submitted by one reporting person and executed by Michael R. Herman as attorney-in-fact.
This report documents a stock-based compensation event for a director and provides the post-transaction share total; no other classes of securities or material terms beyond the issuance for director fees are disclosed in the filing.
Peter Linneman, a director of Regency Centers Corporation (REG), was awarded 350 shares as director fees paid in stock under the company’s Omnibus Incentive Plan on 08/08/2025. The awards were reported on a Form 4 filing and reflect compensation for board service rather than a market purchase.
Following the reported award, Mr. Linneman’s direct beneficial ownership in Regency Centers is 52,892 shares. No derivative transactions were reported and the filing indicates the ownership is held directly.
Karin Klein, a director of Regency Centers Corporation (REG), was granted 420 shares as director fees under the company’s Omnibus Incentive Plan on 08/08/2025. After the grant she beneficially owns 22,349 shares. The Form 4 reports this non-derivative acquisition as an award of common stock and lists the transaction code and ownership form.
The filing was submitted as a single reporting person Form 4 and signed by Michael R. Herman as Attorney-in-Fact for Karin Klein. The Form notes the shares represent director compensation paid in stock pursuant to the Omnibus Incentive Plan.